These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31494056)

  • 1. Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center.
    Roos E; Strijker M; Franken LC; Busch OR; van Hooft JE; Klümpen HJ; van Laarhoven HW; Wilmink JW; Verheij J; van Gulik TM; Besselink MG
    HPB (Oxford); 2020 Mar; 22(3):405-414. PubMed ID: 31494056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016.
    Wang J; Bo X; Nan L; Wang CC; Gao Z; Suo T; Ni X; Liu H; Lu P; Wang Y; Liu H
    Cancer Med; 2020 Feb; 9(4):1335-1348. PubMed ID: 31876990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.
    Matull WR; Dhar DK; Ayaru L; Sandanayake NS; Chapman MH; Dias A; Bridgewater J; Webster GJ; Bong JJ; Davidson BR; Pereira SP
    Liver Int; 2011 Jan; 31(1):99-107. PubMed ID: 20846273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification?
    Bagante F; Ruzzenente A; Conci S; Rusev BC; Simbolo M; Campagnaro T; Pawlik TM; Luchini C; Iacono C; Scarpa A; Guglielmi A
    HPB (Oxford); 2019 Dec; 21(12):1648-1655. PubMed ID: 31122820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Oncologic Outcomes Following Robotic Liver Resections for Primary Hepatobiliary Malignancies: A Multicenter Study.
    Khan S; Beard RE; Kingham PT; Fong Y; Boerner T; Martinie JB; Vrochides D; Buell JF; Berber E; Kahramangil B; Troisi RI; Vanlander A; Molinari M; Tsung A
    Ann Surg Oncol; 2018 Sep; 25(9):2652-2660. PubMed ID: 29987604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to Recurrence After Surgical Resection and Survival After Recurrence Among Patients with Perihilar and Distal Cholangiocarcinomas.
    Nakanishi Y; Okamura K; Tsuchikawa T; Nakamura T; Noji T; Asano T; Matsui A; Tanaka K; Murakami S; Ebihara Y; Kurashima Y; Narasaki H; Amano T; Shichinohe T; Hirano S
    Ann Surg Oncol; 2020 Oct; 27(11):4171-4180. PubMed ID: 32363510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis and prognostic factors in patients with advanced biliary tract cancer depending on its anatomical location.
    Song BG; Park JK; Kim HS; Kim K; Park JK; Lee KH; Lee KT; Lee JK
    Scand J Gastroenterol; 2019 Jun; 54(6):740-745. PubMed ID: 31136212
    [No Abstract]   [Full Text] [Related]  

  • 10. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
    Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
    World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-operative Sarcopenia Identifies Patients at Risk for Poor Survival After Resection of Biliary Tract Cancers.
    Chakedis J; Spolverato G; Beal EW; Woelfel I; Bagante F; Merath K; Sun SH; Chafitz A; Galo J; Dillhoff M; Cloyd J; Pawlik TM
    J Gastrointest Surg; 2018 Oct; 22(10):1697-1708. PubMed ID: 29855867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
    Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of fatty-acid-binding protein 5 in intrahepatic and extrahepatic cholangiocarcinoma: the possibility of different energy metabolisms in anatomical location.
    Nakagawa R; Hiep NC; Ouchi H; Sato Y; Harada K
    Med Mol Morphol; 2020 Mar; 53(1):42-49. PubMed ID: 31432248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
    Utsumi M; Kitada K; Tokunaga N; Yoshida Y; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
    Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major postoperative complications compromise oncological outcomes of patients with intrahepatic cholangiocarcinoma after curative resection - A 13-year cohort in a tertiary center.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Tsang SHY; Lo CM
    Asian J Surg; 2019 Jan; 42(1):164-171. PubMed ID: 29472064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features and prognosis of advanced biliary carcinoma centered in the cystic duct.
    Nakanishi Y; Tsuchikawa T; Okamura K; Nakamura T; Noji T; Asano T; Tanaka K; Shichinohe T; Mitsuhashi T; Hirano S
    HPB (Oxford); 2018 Jan; 20(1):28-33. PubMed ID: 28890312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery for Recurrent Biliary Tract Cancer: A Single-center Experience With 74 Consecutive Resections.
    Takahashi Y; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Nimura Y; Nagino M
    Ann Surg; 2015 Jul; 262(1):121-9. PubMed ID: 25405563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatopancreatoduodenectomy: its suitability for bile duct cancer versus gallbladder cancer.
    Kaneoka Y; Yamaguchi A; Isogai M
    J Hepatobiliary Pancreat Surg; 2007; 14(2):142-8. PubMed ID: 17384904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy.
    Natsume S; Ebata T; Yokoyama Y; Igami T; Sugawara G; Shimoyama Y; Nagino M
    Ann Surg; 2012 Apr; 255(4):754-62. PubMed ID: 22367444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma.
    Lee GC; Gamblin TC; Fong ZV; Ferrone CR; Goyal L; Lillemoe KD; Blaszkowsky LS; Tanabe KK; Qadan M
    Ann Surg Oncol; 2019 Nov; 26(12):4091-4099. PubMed ID: 31368018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.